iGan Partners

iGan Partners, established in 1999, is a Canadian venture capital firm based in Toronto. It specializes in early-stage investments, focusing on healthcare and technology sectors, particularly Digital Health and B2B SaaS. The firm provides not just capital, but also active management support and access to a network of industry partners and co-investors to help portfolio companies succeed. iGan's team, having built and grown successful companies themselves, understands the challenges faced by early-stage businesses and leverages this experience to empower dynamic management teams.

Michael Aron

Co-Founding Partner

Julie Coles

Associate

Joel Finlayson

Venture Partner

Sam Ifergan

Co-Founder and Managing Partner

Nancy Sandhu

Director of Finance and Investments

Tom Steen

Investment Relations Partner

Gary Wang

Senior Associate

45 past transactions

Segmed

Series A in 2024
Segmed, Inc. is a company based in Menlo Park, California, that specializes in providing cloud-based solutions for accessing curated and anonymized radiology data. Established in 2019, Segmed offers customized datasets tailored to the specific needs of its clients in the pharmaceutical and medical device sectors. Its platform supports the development of predictive models and enhances patient recruitment and data management, facilitating research and regulatory processes within the life sciences and technology industries. By focusing on de-identified and structured medical imaging data, Segmed aims to improve early disease detection and prediction while ensuring that findings are accessible and representative of diverse populations.

MolecuLight

Series C in 2024
MolecuLight specializes in innovative imaging solutions for wound care, focusing on the detection of harmful bacteria and accurate wound measurement. The company develops portable handheld optical imaging devices that allow medical practitioners to visualize bacteria and assess wound status directly at the point of care. These devices facilitate the analysis and visual detection of bacteria, provide procedural guidance, and enable the assessment of viable and nonviable tissue. By offering these capabilities, MolecuLight supports healthcare professionals in selecting appropriate therapies for their patients and effectively monitoring wound healing progress.

RetiSpec

Series A in 2024
RetiSpec is a company focused on advancing early detection of Alzheimer’s Disease through its innovative non-invasive eye scanning technology. By employing AI-driven retinal imaging, RetiSpec's solution enables healthcare providers to identify neurodegenerative disease markers during a simple eye exam. This approach facilitates early diagnosis, allowing clinicians to intervene with emerging therapeutics before symptoms arise, thereby potentially impacting the progression of the disease. RetiSpec aims to make early detection accessible and affordable, contributing significantly to the management of Alzheimer's Disease.

Flosonics Medical

Series C in 2024
Flosonics Medical is a Canadian medical device company founded in 2017, specializing in the development of non-invasive sensors aimed at enhancing the management of critically ill patients. Its flagship product, the FloPatch, is a wearable ultrasound sensor designed to monitor blood flow in patients post-clinical intervention, thereby addressing critical clinical needs. The FloPatch is particularly beneficial for healthcare professionals, including physicians, nurses, and paramedics, operating in various high-pressure environments such as ambulances, emergency departments, operating rooms, and intensive care units. The device is notable for its portability, wireless connectivity with tablets and other medical equipment, and user-friendly functionality, all of which contribute to improved patient care in urgent medical situations. Flosonics Medical, previously known as Ke2 Technologies, rebranded in September 2017.

Segmed

Seed Round in 2022
Segmed, Inc. is a company based in Menlo Park, California, that specializes in providing cloud-based solutions for accessing curated and anonymized radiology data. Established in 2019, Segmed offers customized datasets tailored to the specific needs of its clients in the pharmaceutical and medical device sectors. Its platform supports the development of predictive models and enhances patient recruitment and data management, facilitating research and regulatory processes within the life sciences and technology industries. By focusing on de-identified and structured medical imaging data, Segmed aims to improve early disease detection and prediction while ensuring that findings are accessible and representative of diverse populations.

Okadoc

Series B in 2022
Okadoc is a healthtech start-up focused on enhancing the healthcare experience by offering the region’s first instant online appointment booking platform. This platform connects patients with healthcare providers across more than 130 specialities, allowing users to find doctors who accept their insurance, book appointments online, and manage their schedules through features like reminders, rescheduling, and cancellation. Okadoc provides a 24/7 intelligent medical calendar system and a cloud-based solution that integrates with existing hospital and clinic management systems, helping practitioners and healthcare facilities reduce appointment no-shows and optimize patient bookings. The platform also includes a telemedicine feature, facilitating virtual consultations to connect patients with doctors nationwide. Available for free to patients through its website and mobile app, Okadoc aims to deliver a seamless and efficient healthcare experience for users at any time and from any location.

MolecuLight

Venture Round in 2022
MolecuLight specializes in innovative imaging solutions for wound care, focusing on the detection of harmful bacteria and accurate wound measurement. The company develops portable handheld optical imaging devices that allow medical practitioners to visualize bacteria and assess wound status directly at the point of care. These devices facilitate the analysis and visual detection of bacteria, provide procedural guidance, and enable the assessment of viable and nonviable tissue. By offering these capabilities, MolecuLight supports healthcare professionals in selecting appropriate therapies for their patients and effectively monitoring wound healing progress.

Cosm Medical

Seed Round in 2022
Cosm Medical is a health-tech startup focused on developing and commercializing a software-enabled medical device platform aimed at improving the lives of women affected by pelvic floor disorders. The company specializes in creating custom-made gynecological prosthetics that provide personalized therapies for these conditions. By integrating a proprietary ultrasound-based measurement system with data science and three-dimensional printing, Cosm Medical offers a platform that enables the production of tailored synthetic or custom prosthetic solutions. This innovative approach ensures that women receive individualized care in addressing pelvic health issues.

Curv Health

Seed Round in 2022
Curv Health is a multidisciplinary virtual clinic founded in 2017, with offices located in Toronto and Halifax. The company provides a health technology platform that enables healthcare providers to create and manage their own digital practices. Curv Health focuses on enhancing mental performance coaching accessibility, allowing young athletes to receive comprehensive support for their mental health. Through its platform, patients can schedule both virtual and in-person sessions with a range of allied healthcare professionals, including physiotherapists, dietitians, psychotherapists, and counselors. By facilitating this digital care network, Curv Health aims to improve the overall well-being of individuals and increase the number of meaningful years lived globally.

Hyivy

Pre Seed Round in 2021
Hyivy Health develops an innovative pelvic rehabilitation device aimed at addressing the needs of women who experience pelvic health complications. Recognizing that one in three women will face such challenges in their lifetime, the company provides a solution that offers quantifiable data on the pelvic floor. This device incorporates multiple biosensors and mechanical functions to deliver three distinct therapies, enabling effective treatment monitoring and personalized rehabilitation. By allowing both patients and clinicians to track progress and adapt treatment plans, Hyivy Health enhances the overall rehabilitation experience, making it more effective and comfortable.

Marble

Series A in 2021
Marble is a technology company that operates a cloud-based platform designed to facilitate access to patient-consented health data through an API. Founded in 2014 and based in Toronto, Canada, Marble connects to an extensive health data network, serving various industries including legal, consumer health, insurance, and life sciences. Its solutions enable businesses to retrieve and manage healthcare records, thereby enhancing the sharing and utilization of medical information. The company's offerings include a range of documents, such as legal, hospital, clinical, and research materials, aimed at improving the efficiency and accessibility of health data for both providers and patients.

Flosonics Medical

Venture Round in 2021
Flosonics Medical is a Canadian medical device company founded in 2017, specializing in the development of non-invasive sensors aimed at enhancing the management of critically ill patients. Its flagship product, the FloPatch, is a wearable ultrasound sensor designed to monitor blood flow in patients post-clinical intervention, thereby addressing critical clinical needs. The FloPatch is particularly beneficial for healthcare professionals, including physicians, nurses, and paramedics, operating in various high-pressure environments such as ambulances, emergency departments, operating rooms, and intensive care units. The device is notable for its portability, wireless connectivity with tablets and other medical equipment, and user-friendly functionality, all of which contribute to improved patient care in urgent medical situations. Flosonics Medical, previously known as Ke2 Technologies, rebranded in September 2017.

Adracare

Seed Round in 2019
Adracare is a comprehensive clinical management solution tailored for specialty clinics, particularly in the fields of therapy and mental health. The company offers a robust software platform that includes features such as HD video conferencing, online booking, invoicing, group conferencing, and patient reminders. Adracare emphasizes patient engagement through virtual care and integrates electronic medical records (EMR) to streamline workflows, thereby enhancing productivity for healthcare professionals. With a strong focus on security, all data is protected in compliance with HIPAA, PHIPA, and PIPEDA regulations, employing end-to-end encryption to ensure confidentiality. By consolidating essential tools into a single platform, Adracare enables practices to concentrate on delivering high-quality patient care.

RetiSpec

Non Equity Assistance in 2019
RetiSpec is a company focused on advancing early detection of Alzheimer’s Disease through its innovative non-invasive eye scanning technology. By employing AI-driven retinal imaging, RetiSpec's solution enables healthcare providers to identify neurodegenerative disease markers during a simple eye exam. This approach facilitates early diagnosis, allowing clinicians to intervene with emerging therapeutics before symptoms arise, thereby potentially impacting the progression of the disease. RetiSpec aims to make early detection accessible and affordable, contributing significantly to the management of Alzheimer's Disease.

CBx Data Labs

Seed Round in 2019
CBx Data Labs is a provider of software solutions designed to enhance the management of clinical trials, patient outcome tracking, and medication management, particularly in the realm of medical cannabis treatment. The company's cloud-based platform integrates seamlessly with hardware devices, patients, and healthcare professionals, facilitating the collection of medical data. This innovative approach allows healthcare providers to oversee the entire cycle of care, gaining insights into the effectiveness of specific treatment protocols in real-world applications. By streamlining data collection and management, CBx Data Labs aims to improve patient outcomes and advance the understanding of medical cannabis therapies.

SomaDetect

Seed Round in 2019
SomaDetect Inc. is an agricultural technology company based in Fredericton, Canada, founded in 2016. The company specializes in providing dairy farmers with real-time analytics of milk components through advanced sensor technology. SomaDetect's innovative system measures critical indicators such as fat content and somatic cell counts in raw milk during each milking session. By offering automated and chemical-free analysis, the company empowers farmers to identify potential issues early, manage herd health effectively, reduce unnecessary antibiotic use, and ensure high-quality milk is delivered to bulk supplies. With a focus on leveraging machine learning and artificial intelligence, SomaDetect aims to enhance decision-making for dairy farmers, ultimately improving the quality of milk production.

FlipGive

Series A in 2019
FlipGive is a team funding platform focused on transforming how youth sports teams raise money. The company enables members to pool their spending as a group, earning cash back from everyday purchases such as groceries, gas, clothing, equipment, dining, and travel. By creating a direct digital channel between more than 700 merchant partners and the North American youth sports market, FlipGive aggregates the traditionally fragmented market, allowing teams to manage their funds and collect donations efficiently. This innovative approach simplifies fundraising for youth sports teams, making it easier for them to secure financial support while fostering customer loyalty for participating brands.

eSight

Debt Financing in 2019
eSight Corporation develops innovative wearable electronic glasses aimed at enhancing vision for individuals with severe visual impairments, including conditions such as macular degeneration, retinopathy of prematurity, and diabetic retinopathy. The company's flagship product features a high-definition camera and OLED screens to capture and display real-time video, allowing users to adjust visual settings for improved clarity and detail. This technology empowers users to engage in everyday activities and pursue their interests without the limitations imposed by traditional assistive devices. Founded in 2006 and headquartered in Toronto, Canada, eSight also maintains offices in Ottawa, Los Angeles, Nashville, and Switzerland, serving customers primarily in Canada and the United States.

Finaeo

Seed Round in 2019
FINAEO Inc. is a Toronto-based company founded in 2016 that specializes in developing digital applications for the life and health insurance sector. Its all-in-one platform serves as a digital assistant and sales coach for financial advisors, enabling users to share documents, track tasks, answer questions, and schedule meetings on both iOS and Android devices. FINAEO’s digital marketplace effectively connects insurance carriers, brokers, and clients, streamlining policy fulfillment and enhancing distribution processes. By empowering independent brokers, the company aims to improve efficiency and foster growth within the insurance industry.

Rna Diagnostics

Series A in 2018
Rna Diagnostics Inc. is a Toronto-based cancer diagnostics company established in 2010. It specializes in developing innovative medical diagnostic tools aimed at improving cancer management and patient outcomes. The company's flagship product, the RNA Disruption Assay, provides oncologists with a means to evaluate the effectiveness of chemotherapy by measuring the degree of ribosomal RNA disruption, a biomarker indicative of impending cell death. This assessment allows healthcare providers to determine whether the current cancer treatment is beneficial, thereby enabling them to avoid unnecessary side effects and consider alternative therapies that could enhance survival rates. Rna Diagnostics serves a diverse clientele, including patients, healthcare systems, and clinical research centers across Canada, Europe, and the United States, with its laboratory located in Ontario, Canada.

BrainFx

Seed Round in 2018
BrainFx is a company founded by occupational therapists Tracy Milner and Heather Condello, who have significant experience in neurorehabilitation for both adults and children. Established after years of operating an Ontario-based occupational therapy practice, BrainFx addresses the pressing need for comprehensive assessment tools tailored for individuals with neurological deficits. The company's neurological assessment platform is designed to identify the subtle effects of brain disorders, including mild to moderate brain injuries, learning disabilities, concussions, mental illnesses, and cognitive impairments associated with chronic conditions. By providing a suite of clinical assessments, BrainFx enables healthcare providers to measure the functional impacts of these disorders and develop personalized care plans for their patients. The founders are committed to integrating their clinical expertise with the latest research and technology to enhance neurofunctional assessment and intervention, aiming to positively affect the lives of individuals globally.

Marble

Seed Round in 2018
Marble is a technology company that operates a cloud-based platform designed to facilitate access to patient-consented health data through an API. Founded in 2014 and based in Toronto, Canada, Marble connects to an extensive health data network, serving various industries including legal, consumer health, insurance, and life sciences. Its solutions enable businesses to retrieve and manage healthcare records, thereby enhancing the sharing and utilization of medical information. The company's offerings include a range of documents, such as legal, hospital, clinical, and research materials, aimed at improving the efficiency and accessibility of health data for both providers and patients.

Flosonics Medical

Seed Round in 2018
Flosonics Medical is a Canadian medical device company founded in 2017, specializing in the development of non-invasive sensors aimed at enhancing the management of critically ill patients. Its flagship product, the FloPatch, is a wearable ultrasound sensor designed to monitor blood flow in patients post-clinical intervention, thereby addressing critical clinical needs. The FloPatch is particularly beneficial for healthcare professionals, including physicians, nurses, and paramedics, operating in various high-pressure environments such as ambulances, emergency departments, operating rooms, and intensive care units. The device is notable for its portability, wireless connectivity with tablets and other medical equipment, and user-friendly functionality, all of which contribute to improved patient care in urgent medical situations. Flosonics Medical, previously known as Ke2 Technologies, rebranded in September 2017.

Triage

Seed Round in 2018
Triage is an innovative online health technology company that specializes in skin testing and symptom checking. Utilizing an AI-powered smartphone camera, Triage offers a range of services aimed at detecting various medical conditions, including skin diseases such as acne, rashes, and psoriasis, as well as concerns related to eyes, STIs, oral health, hair, and nails. The application enables users to capture photos of their symptoms, which are then analyzed to provide insights into their health issues. This technology allows healthcare professionals to assist patients more effectively by providing accurate information about their conditions, all from the convenience of a mobile device. Triage is committed to improving health monitoring and management through accessible and precise diagnostic tools.

Cosm Medical

Pre Seed Round in 2018
Cosm Medical is a health-tech startup focused on developing and commercializing a software-enabled medical device platform aimed at improving the lives of women affected by pelvic floor disorders. The company specializes in creating custom-made gynecological prosthetics that provide personalized therapies for these conditions. By integrating a proprietary ultrasound-based measurement system with data science and three-dimensional printing, Cosm Medical offers a platform that enables the production of tailored synthetic or custom prosthetic solutions. This innovative approach ensures that women receive individualized care in addressing pelvic health issues.

KF Beauty

Series A in 2017
KF Beauty identifies, develops and markets innovative products in the Health & Beauty sector. Marketing is executed in a unique overlapping of Content, Influencer and Traditional advertising resulting in low CPA, and high customer lifetime value.  The company is focused on a better way to launch and grow brands in the US & European marketplace, utilising technology and a disciplined approach to brand building.

Finaeo

Pre Seed Round in 2017
FINAEO Inc. is a Toronto-based company founded in 2016 that specializes in developing digital applications for the life and health insurance sector. Its all-in-one platform serves as a digital assistant and sales coach for financial advisors, enabling users to share documents, track tasks, answer questions, and schedule meetings on both iOS and Android devices. FINAEO’s digital marketplace effectively connects insurance carriers, brokers, and clients, streamlining policy fulfillment and enhancing distribution processes. By empowering independent brokers, the company aims to improve efficiency and foster growth within the insurance industry.

SceneDoc

Venture Round in 2017
SceneDoc Inc. is a Canadian company based in Mississauga that specializes in developing a mobile-first software platform for data collection, digital evidence management, and workflow optimization specifically designed for law enforcement and public safety agencies. Founded in 2011 and renamed SceneDoc in 2013, the company offers a comprehensive solution that allows front line officers, field agents, and specialized crime scene teams to capture, store, and retrieve data and multimedia seamlessly from their mobile devices. By streamlining the reporting process, SceneDoc enables agencies to save significant time on paperwork, allowing personnel to focus more on community engagement and operational efficiency. As a subsidiary of Tyler Technologies, Inc., SceneDoc continues to innovate within the public safety sector, emphasizing clarity and control through advanced mobile technology.

Right Health

Seed Round in 2017
Right Health is dedicated to enhancing healthcare accessibility and engagement for Canadians by offering a blend of virtual and in-person medical services. The company collaborates with prominent healthcare providers to streamline patient access through an intuitive consumer portal and mobile application. This platform is integrated with patients' electronic medical records, ensuring that individuals can easily manage their health information and receive timely care. By focusing on both digital and traditional care methods, Right Health aims to improve the overall health outcomes for its users.

Exact Imaging

Series C in 2017
Exact Imaging is a Canadian company based in Markham that specializes in developing high-resolution micro-ultrasound systems for urological applications, particularly in the diagnosis and treatment of prostate cancer. The flagship ExactVu system operates at 29 MHz, providing exceptional imaging resolution that allows for the visualization and targeting of suspicious regions within the prostate. This technology facilitates both targeted and systematic TRUS biopsies, enhancing the accuracy of prostate cancer diagnostics. Additionally, Exact Imaging offers the FusionVu application, which integrates micro-ultrasound with MRI data to further improve imaging and biopsy guidance. Founded in 2003 and originally named Imagistx, Inc., the company rebranded to Exact Imaging in March 2015.

Meta

Convertible Note in 2016
Meta is a company focused on transforming the experience and consumption of scientific knowledge through artificial intelligence. It provides an AI-based search engine that efficiently organizes and analyzes scientific research papers, allowing researchers to sort and access new publications based on specific subject matter. By offering powerful insights into the trajectories of science and technology, Meta aims to make all scientific knowledge computable, thus supporting innovators across the scientific ecosystem. The company's mission centers on unlocking the world's scientific and technical insights, facilitating a more comprehensive understanding of complex information.

Think Research

Venture Round in 2016
Think Research, established in 2006, is a Canadian healthcare technology company specializing in knowledge-based tools for clinicians at the point of care. It addresses complex challenges faced by healthcare organizations through practical, cost-effective solutions that leverage artificial intelligence and machine learning. The company offers clinical content, knowledge translation services, partner apps like eMED-PASS and how2track, and platforms such as EntryPoint. Its cloud-based, EMR-agnostic digital tools serve enterprise clients, hospitals, health regions, professionals, and governments worldwide, empowering clinicians to improve patient outcomes across various care settings.

Limelight Platform

Seed Round in 2016
Limelight Platform, Inc. is a Toronto-based company that specializes in providing a software-as-a-service (SaaS) platform designed for automated, data-driven live marketing campaigns. The platform offers a comprehensive suite of tools that includes live strategy, activation tools, consumer communication, social amplification, and real-time data analysis, enabling businesses to effectively manage their live marketing initiatives. Limelight Platform caters to various marketing needs, including mall tours, contests and surveys, events, experiential marketing, in-store experiences, kiosks, samplings, sponsorships, and test drives. Founded in 2014 by Jonah Midanik and Russ Armstrong, the company focuses on enhancing consumer engagement through innovative marketing solutions.

eSight

Series B in 2015
eSight Corporation develops innovative wearable electronic glasses aimed at enhancing vision for individuals with severe visual impairments, including conditions such as macular degeneration, retinopathy of prematurity, and diabetic retinopathy. The company's flagship product features a high-definition camera and OLED screens to capture and display real-time video, allowing users to adjust visual settings for improved clarity and detail. This technology empowers users to engage in everyday activities and pursue their interests without the limitations imposed by traditional assistive devices. Founded in 2006 and headquartered in Toronto, Canada, eSight also maintains offices in Ottawa, Los Angeles, Nashville, and Switzerland, serving customers primarily in Canada and the United States.

Meta

Series A in 2015
Meta is a company focused on transforming the experience and consumption of scientific knowledge through artificial intelligence. It provides an AI-based search engine that efficiently organizes and analyzes scientific research papers, allowing researchers to sort and access new publications based on specific subject matter. By offering powerful insights into the trajectories of science and technology, Meta aims to make all scientific knowledge computable, thus supporting innovators across the scientific ecosystem. The company's mission centers on unlocking the world's scientific and technical insights, facilitating a more comprehensive understanding of complex information.

Augur

Seed Round in 2015
Augur provides Ad-Tech agencies with cross-device and cross-channel attribution analytics.

SceneDoc

Series A in 2015
SceneDoc Inc. is a Canadian company based in Mississauga that specializes in developing a mobile-first software platform for data collection, digital evidence management, and workflow optimization specifically designed for law enforcement and public safety agencies. Founded in 2011 and renamed SceneDoc in 2013, the company offers a comprehensive solution that allows front line officers, field agents, and specialized crime scene teams to capture, store, and retrieve data and multimedia seamlessly from their mobile devices. By streamlining the reporting process, SceneDoc enables agencies to save significant time on paperwork, allowing personnel to focus more on community engagement and operational efficiency. As a subsidiary of Tyler Technologies, Inc., SceneDoc continues to innovate within the public safety sector, emphasizing clarity and control through advanced mobile technology.

Vemba

Seed Round in 2014
Vemba is a digital publishing technology platform that specializes in video distribution. It offers a player-agnostic solution that enables publishers to seamlessly integrate third-party video content and advertising into their existing editorial processes and workflows. This approach allows media companies to maintain better control over their content while featuring original and complementary videos without the complications associated with third-party players or advertising restrictions. By positioning itself at the center of content transactions, Vemba provides both content owners and publishers with real-time analytics on the performance of their videos and advertisements, irrespective of the underlying video player, ad server, or content delivery network. This functionality aims to enhance audience engagement and maximize revenue potential for media companies.

MolecuLight

Seed Round in 2014
MolecuLight specializes in innovative imaging solutions for wound care, focusing on the detection of harmful bacteria and accurate wound measurement. The company develops portable handheld optical imaging devices that allow medical practitioners to visualize bacteria and assess wound status directly at the point of care. These devices facilitate the analysis and visual detection of bacteria, provide procedural guidance, and enable the assessment of viable and nonviable tissue. By offering these capabilities, MolecuLight supports healthcare professionals in selecting appropriate therapies for their patients and effectively monitoring wound healing progress.

eSight

Venture Round in 2014
eSight Corporation develops innovative wearable electronic glasses aimed at enhancing vision for individuals with severe visual impairments, including conditions such as macular degeneration, retinopathy of prematurity, and diabetic retinopathy. The company's flagship product features a high-definition camera and OLED screens to capture and display real-time video, allowing users to adjust visual settings for improved clarity and detail. This technology empowers users to engage in everyday activities and pursue their interests without the limitations imposed by traditional assistive devices. Founded in 2006 and headquartered in Toronto, Canada, eSight also maintains offices in Ottawa, Los Angeles, Nashville, and Switzerland, serving customers primarily in Canada and the United States.

Meta

Seed Round in 2014
Meta is a company focused on transforming the experience and consumption of scientific knowledge through artificial intelligence. It provides an AI-based search engine that efficiently organizes and analyzes scientific research papers, allowing researchers to sort and access new publications based on specific subject matter. By offering powerful insights into the trajectories of science and technology, Meta aims to make all scientific knowledge computable, thus supporting innovators across the scientific ecosystem. The company's mission centers on unlocking the world's scientific and technical insights, facilitating a more comprehensive understanding of complex information.

Exact Imaging

Venture Round in 2013
Exact Imaging is a Canadian company based in Markham that specializes in developing high-resolution micro-ultrasound systems for urological applications, particularly in the diagnosis and treatment of prostate cancer. The flagship ExactVu system operates at 29 MHz, providing exceptional imaging resolution that allows for the visualization and targeting of suspicious regions within the prostate. This technology facilitates both targeted and systematic TRUS biopsies, enhancing the accuracy of prostate cancer diagnostics. Additionally, Exact Imaging offers the FusionVu application, which integrates micro-ultrasound with MRI data to further improve imaging and biopsy guidance. Founded in 2003 and originally named Imagistx, Inc., the company rebranded to Exact Imaging in March 2015.

FlipGive

Seed Round in 2012
FlipGive is a team funding platform focused on transforming how youth sports teams raise money. The company enables members to pool their spending as a group, earning cash back from everyday purchases such as groceries, gas, clothing, equipment, dining, and travel. By creating a direct digital channel between more than 700 merchant partners and the North American youth sports market, FlipGive aggregates the traditionally fragmented market, allowing teams to manage their funds and collect donations efficiently. This innovative approach simplifies fundraising for youth sports teams, making it easier for them to secure financial support while fostering customer loyalty for participating brands.

Quandl

Seed Round in 2012
Quandl Inc. is a data platform based in Toronto, Canada, that specializes in providing financial, economic, and alternative datasets tailored for investment professionals, including analysts from leading hedge funds, asset managers, and investment banks. Founded in 2011, the company sources and evaluates undiscovered data assets, transforming them into actionable intelligence that supports the decision-making and trading strategies of its clients. Quandl offers a robust delivery system that includes access to core financial data, market data, and unique alternative data through various tools such as API, Python, R, and Excel. Additionally, the platform allows for the bundling of multiple datasets and provides a revenue-sharing model for publishers who share their information on its portal. Originally known as Wikiposit Inc., the company rebranded to Quandl Inc. in 2012 and has since established itself as a key player in the financial data landscape. As of late 2018, Quandl operates as a subsidiary of Nasdaq, Inc.

Cyborg

We develop Cyborg Cloud Search, the world's first encrypted search for the cloud.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.